ON DEMAND: 2021 Update: What's New in the Field of Multiple Sclerosis

Tuesday, June 1, 2021, 12:17 PM - Friday, May 31, 2024, 1:17 PM

Multiple Sclerosis (MS) is the most frequent non-traumatic cause for disability among young adults in North America and Europe. Worldwide, about 2.5 million people are affected. In the United States alone, almost 1 million individuals suffer from MS. There have been tremendous strides taken in the field of multiple sclerosis over the past several years including new diagnostic criteria & new treatment strategies.

This on demand webinar is designed to educate clinicians and other health care professionals on advances in the diagnosis and management of patients with multiple sclerosis.

Lectures Included: 

Overview of MS Pathophysiology and How Therapies Work - David Hafler MD 

A Unified View of MS - David Pitt MD MS Genetics - Matthew Lincoln MD, PhD

MRI Update - Christina Azevedo MD

Vaccines in MS, Known and Unknown - Jeffrey Gross, MD

NMO: A Medication Update - Brian Weinshenker MD

Living with MS during Times of COVID - Erin Longbrake MD, PhD

Technological Advances in MS: How Apps and Telehealth  Could Improve Patient Care -  Sharon S. Stoll DO, MS

Covid-19 in MS Methodological Issues in the Interpretation of the Italian Registry Data - Maria Pia Sormani MD

1. Examine the current understanding of the genetics and pathophysiology of multiple sclerosis
2. Discuss new and emerging treatments in MS and the risk benefit ratio of newer agents compared to older therapies
3. Review MS disease-modifying therapies and the COVID-19 Pandemic
4. Discuss how current and future biomarkers might create individualized treatment plans
5. Explore current MS apps and technology to better educate and evaluate patients

Registration fee - $40
YNHHS Faculty & Staff - complimentary, registration required

If paying via check, include conference name in the memo, make check payable to Yale University and send to: Yale CME c/o Allison Rentfro 333 Cedar Street Box 208052 New Haven, CT 06520-8052

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The Yale School of Medicine designates this enduring material for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs.  All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

AMA PRA Category 1 Credits™ (3.00 hours), Non-Physician Attendance (3.00 hours)

Mitigation of Relevant Financial Relationships

Yale Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.